Dr. Muhammad Ahmad Mujtaba, MD

Dr. Mujtaba practices at US Renal Care Space City Dialysis in League City, Texas.

Dr. Mujtaba's NPI, 1740426592, was assigned on December 29, 2008. Dr. Mujtaba graduated from Allama Iqbal Medical College in 2000. Dr. Mujtaba's Indiana license number on file is 01066894A.

Dr. Mujtaba's primary practice is US Renal Care Space City Dialysis, at 2301 Carina Ct, League City, TX 77573 in Galveston County. The practice phone is (713) 425-0428.

Dr. Mujtaba's primary practice is US Renal Care Space City Dialysis in League City, Texas. Dr. Mujtaba is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Mujtaba to 3 more hospitals, 4 medical groups, 3 dialysis centers and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mujtaba practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mujtaba's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mujtaba is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Mujtaba's licenses on file in 5 states: Indiana, Texas, West Virginia, Oklahoma and Illinois.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Mujtaba treats.

CMS data shows 494 Medicare services from Dr. Mujtaba across 8 procedure codes in 2024, for 226 Medicare patients. Medicare paid $33,470 for them.

CMS counts 226 Medicare patients who saw Dr. Mujtaba in 2024. The largest group is under 65, with 109 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 4.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mujtaba's median patient age at 69, with 50% women.

In 2024, Dr. Mujtaba wrote 2,875 Medicare Part D claims for 378 patients. 85% of them were for generic drugs. CMS names the drug for 2,471 of them, across 42 drugs with 11 or more claims each, at $639,536 in total drug cost. In 2023, CMS named 1,808 claims across 34 drugs.

Dr. Mujtaba accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 52 papers to Dr. Mujtaba, published from 2010 to 2024. 2022 was the busiest year, with 9. The most frequent topics are Kidney Transplantation, Graft Rejection and Graft Survival. Dr. Mujtaba has published most often in Clin Transplant. Dr. Mujtaba's most frequent co-authors are Michael Louis Kueht, Rupak Dilip Kulkarni, MD and Asif Aziz Sharfuddin, MD.

Dmand AI links Dr. Mujtaba to 1 clinical trial.

CMS Open Payments shows 88 general payments to Dr. Mujtaba from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Mallinckrodt Hospital Products Inc. paid the most, $69,975.

Dmand AI lists 2 awards for Dr. Mujtaba, most recently Fellow of American Society of Transplant (FAST) in 2015.

Dr. Mujtaba graduated from Allama Iqbal Medical College in 2000. Dr. Mujtaba is a member of ASN.

Dr. Mujtaba is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.